Smoking quit support for adults living with HIV in South Africa
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests smoking-cessation interventions to help people living with HIV quit smoking or smoke less. You may be eligible if you smoke, are actively engaged in HIV treatment, and can follow the study for about a year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You attend one of the study clinics in South Africa
- You have confirmed HIV and have been taking HIV treatment for at least 3 months (or meet a recent-time requirement)
- You currently smoke and meet proof checks (smoking history plus breath and urine tests)
- You have access to a mobile phone and can sign written consent
- You are not currently using smoking-quit counseling or medicine (within the last 14 days)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 4 study tests a smoking-quit support approach (reinforcement and coaching) to help people with HIV stop smoking and stay smoke-free. It may help improve smoking abstinence while you continue HIV care.
This study tests a wellness-based smoking-cessation program (including the stop-smoking medicine varenicline) for people living with HIV who want to quit. It aims to help you reduce or stop smoking while monitoring safety, sleep, and mental health during the program.
This study tests whether nicotine replacement therapy (like patches or gum) can help people living with HIV quit smoking. You'll be part of a program that supports your quit attempt while you receive care for HIV.
This Phase 3 trial tests a quit-smoking program using varenicline (a medicine) plus additional support, for people with HIV who currently use tobacco. It may help you stop smoking or using tobacco and stay quit with safer, guided care.
This study supports quitting smoking while you are receiving HIV and/or TB care. It aims to improve engagement in care and smoking cessation for people who smoke daily.
This study tests a harm-reduction approach to help people with HIV smoke fewer cigarettes and quit if they want, using an online tobacco program and varenicline (a quit-smoking medicine). You may be placed in one of two different study groups to compare how well the approaches work.
Hear when a new Smoking Cessation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.